Turbocef 750 mg/vial IM/IV Injection 750 mg vial

Name: Beximco Turbocef 750mg price in Bangladesh
Brand: Beximco Pharmaceuticals Ltd
Price: 125.0 BDT
Availability: InStock

Brand: Beximco Pharmaceuticals Ltd

Category: Cefuroxime Axetil

TK. 125

Highlights:

Country of Origin: Bangladesh
Medicine Type : Injection
Medicine Strength: 750 mg

বই ও পণ্যে ৭০% পর্যন্ত ছাড়! বছরের সেরা ডিল, রকমারি ক্লিয়ারেন্স সেল, ২০২৫

Add to Cart

Specification
Title:	Turbocef 750 mg/vial IM/IV Injection 750 mg vial
Brand:	Beximco Pharmaceuticals Ltd
Country of Origin	Bangladesh
Quantity Per Pack	1 Pcs
Medicine Type	Injection
Medicine Strength	750 mg
Brand	Beximco
Form	Vial
Benefit	Relief
Pack Size	1 Vial
Use	Infection
Product name	Beximco Turbocef 750mg
Medicine Type	Injection
Specification	Details
Strength	750mg

Summary

Beximco Turbocef 750mg

The Beximco Turbocef 750mg is a trusted Cefuroxime injection medicine. The broad-spectrum antibiotic effectively and quickly fights bacterial infections. The Bacterial infection treatment is safe and reliable for adults. The injection works speedily and supports a fast recovery. The medicine is available in Bangladesh at an affordable price.

Features and Benefits

✅ Quick Infection Relief: The Beximco Turbocef 750mg reduces bacterial infection symptoms fast and restores health safely.

✅ Fast Symptom Control: Cefuroxime injection calms infection effects quickly and promotes recovery effectively in patients.

✅ Easy Administration: Broad-spectrum antibiotic is simple to use under medical supervision, safely.

✅ Cost-Effective Medicine: The Beximco Turbocef 750mg provides reliable infection treatment without extra expense.

Best Price Offer: The Beximco Turbocef 750mg is available at the best price in Bangladesh on Rokomari.com. Grab it now from us.

Report incorrect information

Brand Information

Beximco Pharmaceuticals Ltd

Beximco Pharmaceuticals Ltd. (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets around the world. Beximco Pharma is consistently building upon its portfolio and currently producing more than 500 products encompassing broad therapeutic categories and the Company has created strong differentiation by offering a range of high-tech, specialized products which are difficult to imitate.